Curative Biotechnology’s Stock Plummets: Why Investors Face High Risks
Curative Biotechnology Inc. faces steep financial risks: a sharp stock plunge, negative P/E, and OTC volatility highlight investor caution needed in biotech.
2 minutes to read
Curative Biotechnology Inc